On 29 March 2023, the UK Health and Safety Executive (HSE) started a 60 day commenting period on the GB mandatory classification and labelling (MCL) proposal for the following substance:
GB MCL consultation launched on Bixlozone
Previous
Previous
2 GB MCL Technical Reports published
Next
Next
